Effects of cigarette smoking and nicotine nasal spray on psychiatric symptoms and cognition in schizophrenia.
about
Cotinine: Beyond that Expected, More than a Biomarker of Tobacco Consumption.Nicotine for schizophreniaNicotinic receptor mechanisms and cognition in normal states and neuropsychiatric disorders.Neuronal nicotinic receptor agonists for the treatment of attention-deficit/hyperactivity disorder: focus on cognitionNew Pharmacological Agents to Aid Smoking Cessation and Tobacco Harm Reduction: What Has Been Investigated, and What Is in the Pipeline?Varenicline Effects on Smoking, Cognition, and Psychiatric Symptoms in Schizophrenia: A Double-Blind Randomized TrialCigarette smoking and cognitive function in Chinese male schizophrenia: a case-control studyTobacco smoking produces widespread dominant brain wave alpha frequency increasesEffects of the phencyclidine model of schizophrenia and nicotine on total and categorized ultrasonic vocalizations in ratsnAChR dysfunction as a common substrate for schizophrenia and comorbid nicotine addiction: Current trends and perspectives.Nicotine effect on prepulse inhibition and prepulse facilitation in schizophrenia patientsNicotinic mechanisms in the treatment of psychotic disorders: a focus on the α7 nicotinic receptorEffects of moderate-dose treatment with varenicline on neurobiological and cognitive biomarkers in smokers and nonsmokers with schizophrenia or schizoaffective disorder.Zebrafish for the study of the biological effects of nicotine.The nicotinic receptor of cochlear hair cells: a possible pharmacotherapeutic target?Correlation of prepulse inhibition and Wisconsin Card Sorting Test in schizophrenia and controls: effects of smoking statusMolecular targets for treating cognitive dysfunction in schizophrenia.Smoking, Genetics and Schizophrenia: Evidence for Self Medication.Treating schizophrenia symptoms with an alpha7 nicotinic agonist, from mice to men.In vivo evidence for β2 nicotinic acetylcholine receptor subunit upregulation in smokers as compared with nonsmokers with schizophrenia.Predictors of early abstinence in smokers with schizophreniaThe effects of galantamine on psychopathology in chronic stable schizophrenia.Chronic cigarette smoking: implications for neurocognition and brain neurobiology.The interactive effects of ketamine and nicotine on human cerebral blood flowAlpha7 nicotinic acetylcholine receptor: a link between inflammation and neurodegeneration.The effect of odor valence on olfactory performance in schizophrenia patients, unaffected relatives and at-risk youth.SSR180711, a novel selective alpha7 nicotinic receptor partial agonist: (II) efficacy in experimental models predictive of activity against cognitive symptoms of schizophrenia.Nicotine enhances but does not normalize visual sustained attention and the associated brain network in schizophreniaReduced nicotine product standards for combustible tobacco: building an empirical basis for effective regulation.Prevalence and correlates of cigarette smoking among Chinese schizophrenia inpatients receiving antipsychotic mono-therapyCognitive effects of very low nicotine content cigarettes, with and without nicotine replacement, in smokers with schizophrenia and controlsNicotine effects in adolescence and adulthood on cognition and α₄β₂-nicotinic receptors in the neonatal ventral hippocampal lesion rat model of schizophrenia.Nicotine improves working memory span capacity in rats following sub-chronic ketamine exposureVarenicline as a smoking cessation aid in schizophrenia: effects on smoking behavior and reward sensitivityEffects of acute abstinence, reinstatement, and mecamylamine on biochemical and behavioral measures of cigarette smoking in schizophrenia.Behavioral effects of phencyclidine on nicotine self-administration and reinstatement in the presence or absence of a visual stimulus in rats.Separate and combined effects of very low nicotine cigarettes and nicotine replacement in smokers with schizophrenia and controlsExtended use of nicotine replacement therapy to maintain smoking cessation in persons with schizophrenia.Shorter interpuff interval is associated with higher nicotine intake in smokers with schizophreniaRyanodine is a positive modulator of acetylcholine receptor gating in cochlear hair cells.
P2860
Q21129280-996E273C-C744-4486-B19E-09E3E7E29183Q24244830-BAAC771F-A8E0-412B-956C-A36E39233D0EQ24532028-E66DEB24-1A55-4165-9D66-760BAB9A56BFQ24614080-21F36684-DB15-472A-BAFF-13BB19124554Q28277165-F5A8240C-6711-4846-A847-952390D44B48Q28552053-C89B83F3-16CF-4F87-807C-ADE8BBB379DBQ28730147-4ED4FF5F-A346-401D-9FA7-CF6DD39FA2C5Q29027974-58A395BF-6C1B-4026-BBD0-48ABA34589CEQ30354969-E69D5206-B888-4EFF-B674-E85F6E3FFE62Q30362464-5DDC9EC8-5FC5-4893-BC5A-FD48AE1F7D8CQ30425458-581A3736-612F-4D4B-8932-5A46B019E95BQ30453198-8A8C442C-3940-4AE6-8DDB-A282AFE6F1DCQ30455599-CFD64EC1-C846-40C5-9283-8104C914EEA7Q30468155-0726AF8C-C356-4CA7-A2E5-39D56D65A83AQ30479273-EAD63632-E8F0-40FC-BF64-DDAF5C85AEE4Q30479419-A7921963-8BEA-4805-8932-4B3C779EF556Q30491310-A9F2D6C7-727B-4210-8E0C-4D59D63509A7Q30491841-212AF193-E75B-425B-BFB8-71779016BF98Q30493072-D3472AF6-D4E5-41F9-AB27-2ADAEBC9BCDCQ33605318-C4638A6E-B310-43F8-BF95-17A352C4A36DQ33679772-E7BF0179-862E-4965-8D64-640A1736D7B2Q33724801-9D8CE20F-3F34-4847-A525-90759DBA0092Q33765602-5F0C8F17-BE67-4436-A7DB-78E6D4CBD2FCQ33937889-2433714B-0E28-4C0E-9E65-74A74C994814Q33955075-7F2D980B-F74F-4D45-8FFF-A728E2F6B479Q34344448-86932913-0B13-4C61-91FB-75CDB4E01FAEQ34561031-B08D7A3A-4450-45EE-97E5-BC23F8B97961Q34604413-B86B0AC7-7477-4FD0-BE0D-02E2DF8BDFF6Q34621879-644AE57B-528B-4335-B31C-E46C3A0D2D32Q35092839-0199E51C-1851-4110-8A27-1F4C153AE622Q35473864-B4BE11B3-1007-4DD7-BFE1-42FB0E3B33CBQ35547417-66E512EE-E3E1-4BCF-BC0C-57F0F52AE26AQ35592077-40016049-7229-4B23-8B10-323265668EC8Q35704853-D711236D-A626-4B63-8799-0F8709AE7D9AQ35880018-3C93581C-4A83-4B2A-8E8E-7E5F6B7DF277Q35889304-F04563A9-F97E-48E1-BBF9-334DC94A6ACDQ36471948-A8FDB83E-D366-4D04-A5A1-D0FE1C6C335BQ36713443-C96B4F49-8FF3-48DA-A9E8-7F46D4DC2B77Q36848924-7E97AAE8-AE09-4254-AEF3-D6A6627121E7Q36881508-46CFBBD2-4827-4BC9-AAF3-3A38BF6C5E3D
P2860
Effects of cigarette smoking and nicotine nasal spray on psychiatric symptoms and cognition in schizophrenia.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
2002年學術文章
@zh-hant
name
Effects of cigarette smoking a ...... nd cognition in schizophrenia.
@en
Effects of cigarette smoking a ...... nd cognition in schizophrenia.
@nl
type
label
Effects of cigarette smoking a ...... nd cognition in schizophrenia.
@en
Effects of cigarette smoking a ...... nd cognition in schizophrenia.
@nl
prefLabel
Effects of cigarette smoking a ...... nd cognition in schizophrenia.
@en
Effects of cigarette smoking a ...... nd cognition in schizophrenia.
@nl
P2093
P1476
Effects of cigarette smoking a ...... nd cognition in schizophrenia.
@en
P2093
Abhay Singh
Amaresh Khandat
Angelica Kloos
Mauricio Infante
Robert C Smith
P304
P356
10.1016/S0893-133X(02)00324-X
P407
P577
2002-09-01T00:00:00Z
P5875
P6179
1042443864